- Home
- IRON vs EVEX Comparison
IRON vs EVEX Comparison
Compare IRON & EVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- EVEX
- Stock Information
- Founded
- IRON 2017
- EVEX 2020
- Country
- IRON United States
- EVEX United States
- Employees
- IRON N/A
- EVEX N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- EVEX Aerospace
- Sector
- IRON Health Care
- EVEX Industrials
- Exchange
- IRON Nasdaq
- EVEX Nasdaq
- Market Cap
- IRON 1.4B
- EVEX 1.3B
- IPO Year
- IRON N/A
- EVEX N/A
- Fundamental
- Price
- IRON $44.24
- EVEX $3.90
- Analyst Decision
- IRON Strong Buy
- EVEX Strong Buy
- Analyst Count
- IRON 10
- EVEX 3
- Target Price
- IRON $83.80
- EVEX $6.00
- AVG Volume (30 Days)
- IRON 397.9K
- EVEX 133.2K
- Earning Date
- IRON 05-07-2025
- EVEX 05-16-2025
- Dividend Yield
- IRON N/A
- EVEX N/A
- EPS Growth
- IRON N/A
- EVEX N/A
- EPS
- IRON N/A
- EVEX N/A
- Revenue
- IRON N/A
- EVEX N/A
- Revenue This Year
- IRON N/A
- EVEX N/A
- Revenue Next Year
- IRON N/A
- EVEX N/A
- P/E Ratio
- IRON N/A
- EVEX N/A
- Revenue Growth
- IRON N/A
- EVEX N/A
- 52 Week Low
- IRON $28.25
- EVEX $2.33
- 52 Week High
- IRON $68.73
- EVEX $6.09
- Technical
- Relative Strength Index (RSI)
- IRON 45.99
- EVEX 56.60
- Support Level
- IRON $40.36
- EVEX $3.41
- Resistance Level
- IRON $47.21
- EVEX $3.97
- Average True Range (ATR)
- IRON 2.87
- EVEX 0.22
- MACD
- IRON 0.10
- EVEX 0.03
- Stochastic Oscillator
- IRON 37.67
- EVEX 88.52
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About EVEX Eve Holding Inc.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.